Paul Winters
Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Medication Adherence | 1 | 2010 | 19 |
Why?
|
Patient-Centered Care | 2 | 2010 | 30 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 34 |
Why?
|
Hypercholesterolemia | 1 | 2010 | 33 |
Why?
|
Primary Health Care | 3 | 2010 | 151 |
Why?
|
Health Promotion | 3 | 2010 | 76 |
Why?
|
Colonoscopy | 2 | 2010 | 25 |
Why?
|
Colorectal Neoplasms | 3 | 2010 | 55 |
Why?
|
Healthcare Disparities | 2 | 2011 | 24 |
Why?
|
Mammography | 2 | 2010 | 32 |
Why?
|
Middle Aged | 16 | 2005 | 1161 |
Why?
|
Coronary Disease | 2 | 2010 | 94 |
Why?
|
Lead | 2 | 2009 | 55 |
Why?
|
Breast Neoplasms | 4 | 2010 | 185 |
Why?
|
Nutrition Surveys | 3 | 2009 | 36 |
Why?
|
Cardiovascular Diseases | 2 | 2009 | 127 |
Why?
|
United States | 7 | 2005 | 604 |
Why?
|
Adult | 13 | 2005 | 1317 |
Why?
|
Early Detection of Cancer | 2 | 2010 | 6 |
Why?
|
Young Adult | 4 | 2009 | 380 |
Why?
|
Social Class | 2 | 2010 | 46 |
Why?
|
Female | 16 | 2005 | 1643 |
Why?
|
Income | 2 | 2010 | 51 |
Why?
|
Neoplasms | 2 | 2010 | 239 |
Why?
|
Aged | 9 | 2007 | 988 |
Why?
|
Health Services Research | 2 | 2010 | 63 |
Why?
|
Poverty | 3 | 2005 | 56 |
Why?
|
Occult Blood | 1 | 2011 | 8 |
Why?
|
Sigmoidoscopy | 1 | 2011 | 14 |
Why?
|
Minority Groups | 1 | 2011 | 38 |
Why?
|
Patient Advocacy | 1 | 2011 | 35 |
Why?
|
Male | 13 | 2005 | 1553 |
Why?
|
Quality Improvement | 1 | 2010 | 12 |
Why?
|
Environmental Exposure | 2 | 2009 | 75 |
Why?
|
Humans | 19 | 2005 | 1856 |
Why?
|
Community Health Centers | 1 | 2010 | 20 |
Why?
|
Peer Review | 1 | 2010 | 13 |
Why?
|
Endometrium | 1 | 2011 | 27 |
Why?
|
Hypertension | 2 | 2010 | 161 |
Why?
|
Hyperlipidemias | 1 | 2010 | 42 |
Why?
|
Hormone Antagonists | 1 | 2011 | 26 |
Why?
|
Vitamin D Deficiency | 1 | 2010 | 27 |
Why?
|
Mifepristone | 1 | 2011 | 30 |
Why?
|
Residence Characteristics | 1 | 2010 | 39 |
Why?
|
Health Status Disparities | 1 | 2010 | 25 |
Why?
|
Continuity of Patient Care | 1 | 2011 | 47 |
Why?
|
Continental Population Groups | 1 | 2010 | 85 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 72 |
Why?
|
Cholesterol, LDL | 1 | 2010 | 23 |
Why?
|
Thymus Gland | 1 | 2010 | 57 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2009 | 9 |
Why?
|
Health Services Accessibility | 1 | 2011 | 72 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2010 | 31 |
Why?
|
Body Weight | 1 | 2010 | 178 |
Why?
|
Carcinoma | 1 | 2010 | 109 |
Why?
|
African Americans | 1 | 2011 | 108 |
Why?
|
Patient Satisfaction | 1 | 2010 | 120 |
Why?
|
Tobacco Use Disorder | 1 | 2008 | 16 |
Why?
|
Outcome Assessment (Health Care) | 1 | 2010 | 163 |
Why?
|
Smoking | 2 | 2008 | 153 |
Why?
|
Kidney Failure, Chronic | 1 | 2007 | 57 |
Why?
|
Stress, Psychological | 1 | 2010 | 117 |
Why?
|
Transients and Migrants | 1 | 2005 | 5 |
Why?
|
Obesity | 1 | 2010 | 149 |
Why?
|
Public Assistance | 1 | 2005 | 6 |
Why?
|
Public Policy | 1 | 2005 | 14 |
Why?
|
Emigration and Immigration | 1 | 2005 | 19 |
Why?
|
Community Networks | 1 | 2005 | 17 |
Why?
|
Inflammation | 1 | 2010 | 208 |
Why?
|
Depression | 1 | 2009 | 118 |
Why?
|
New York | 4 | 2007 | 422 |
Why?
|
Socioeconomic Factors | 3 | 2008 | 144 |
Why?
|
Motivation | 1 | 2005 | 85 |
Why?
|
Decision Making | 1 | 2005 | 130 |
Why?
|
Cross-Sectional Studies | 3 | 2007 | 253 |
Why?
|
Cohort Studies | 3 | 2009 | 332 |
Why?
|
Prevalence | 3 | 2007 | 281 |
Why?
|
Treatment Outcome | 1 | 2010 | 661 |
Why?
|
Risk Assessment | 3 | 2009 | 324 |
Why?
|
Kaplan-Meier Estimate | 2 | 2009 | 89 |
Why?
|
Risk | 2 | 2009 | 203 |
Why?
|
Aged, 80 and over | 3 | 2009 | 599 |
Why?
|
Adolescent | 4 | 2005 | 891 |
Why?
|
Risk Factors | 3 | 2008 | 555 |
Why?
|
Biological Markers | 2 | 2010 | 262 |
Why?
|
Time Factors | 2 | 2010 | 896 |
Why?
|
Unemployment | 1 | 2011 | 10 |
Why?
|
Dyslipidemias | 1 | 2011 | 10 |
Why?
|
American Cancer Society | 1 | 2010 | 5 |
Why?
|
Receptors, Progesterone | 1 | 2011 | 28 |
Why?
|
Health Care Reform | 1 | 2011 | 28 |
Why?
|
Cholesterol | 1 | 2011 | 86 |
Why?
|
Vulnerable Populations | 1 | 2010 | 19 |
Why?
|
Educational Status | 1 | 2011 | 99 |
Why?
|
Urban Population | 1 | 2011 | 80 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 54 |
Why?
|
Poisson Distribution | 1 | 2009 | 18 |
Why?
|
Leiomyoma | 1 | 2011 | 34 |
Why?
|
Workplace | 1 | 2010 | 16 |
Why?
|
Hypertrophy | 1 | 2010 | 46 |
Why?
|
Cause of Death | 1 | 2010 | 82 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2011 | 55 |
Why?
|
Registries | 1 | 2010 | 83 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 123 |
Why?
|
Insurance, Health | 1 | 2011 | 58 |
Why?
|
Vitamin D | 1 | 2010 | 41 |
Why?
|
Leukocyte Count | 1 | 2010 | 94 |
Why?
|
Uterine Neoplasms | 1 | 2011 | 52 |
Why?
|
Needs Assessment | 1 | 2010 | 67 |
Why?
|
African Continental Ancestry Group | 1 | 2010 | 80 |
Why?
|
Radiation Dosage | 1 | 2010 | 65 |
Why?
|
Multivariate Analysis | 1 | 2011 | 225 |
Why?
|
Environmental Monitoring | 1 | 2010 | 28 |
Why?
|
Social Support | 1 | 2011 | 111 |
Why?
|
Lead Poisoning | 1 | 2009 | 32 |
Why?
|
C-Reactive Protein | 1 | 2010 | 54 |
Why?
|
Blood Pressure | 1 | 2011 | 205 |
Why?
|
Survival Analysis | 1 | 2011 | 205 |
Why?
|
Patient Education as Topic | 1 | 2010 | 128 |
Why?
|
European Continental Ancestry Group | 1 | 2010 | 117 |
Why?
|
Survival Rate | 1 | 2011 | 250 |
Why?
|
Fibrinogen | 1 | 2010 | 45 |
Why?
|
Body Mass Index | 1 | 2010 | 122 |
Why?
|
Odds Ratio | 1 | 2009 | 157 |
Why?
|
Dominican Republic | 1 | 2008 | 8 |
Why?
|
Glomerular Filtration Rate | 1 | 2009 | 33 |
Why?
|
Incidence | 1 | 2011 | 336 |
Why?
|
Research Design | 1 | 2010 | 169 |
Why?
|
Analysis of Variance | 1 | 2010 | 339 |
Why?
|
Demography | 1 | 2008 | 87 |
Why?
|
Mass Screening | 1 | 2010 | 125 |
Why?
|
Population Surveillance | 1 | 2008 | 70 |
Why?
|
Logistic Models | 1 | 2009 | 251 |
Why?
|
Reproducibility of Results | 1 | 2010 | 391 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 176 |
Why?
|
Smoking Cessation | 1 | 2008 | 46 |
Why?
|
Residential Mobility | 1 | 2005 | 1 |
Why?
|
Mexico | 1 | 2005 | 5 |
Why?
|
Models, Econometric | 1 | 2005 | 4 |
Why?
|
Family Characteristics | 1 | 2005 | 22 |
Why?
|
Program Evaluation | 1 | 2005 | 115 |
Why?
|
Retrospective Studies | 1 | 2010 | 653 |
Why?
|
Infant | 1 | 2010 | 464 |
Why?
|
Child | 1 | 2005 | 749 |
Why?
|
